BHST NASDAQ
BioHarvest Sciences Inc.
1W: -0.7%
1M: -23.7%
3M: -49.8%
YTD: -72.2%
1Y: -84.3%
$1.47
-0.02 (-1.34%)
Weekly Expected Move ±6.0%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$7M
+21.6% ▲
Capital Expenditures
$3M
-92.3% ▼
5Y CAGR: +142.2%
Free Cash Flow
-$10M
+4.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$3M
-181.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$7M | -$10M | -$11M | -$13M | -$13M |
| Depreciation & Amort. | $288K | $386K | $712K | $840K | $1M |
| Stock-Based Comp. | $1M | $3M | $0 | $563K | $601K |
| Change in Working Capital | -$232K | -$96K | -$308K | $755K | -$555K |
| Other Non-Cash Items | $1M | -$627K | $2M | $2M | $5M |
| Operating Cash Flow | -$4M | -$7M | -$9M | -$9M | -$7M |
| — Investing Activities — | |||||
| Capital Expenditures | -$173K | -$2M | -$1M | -$1M | -$3M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | -$192K |
| Investing Cash Flow | -$173K | -$2M | -$1M | -$1M | -$3M |
| — Financing Activities — | |||||
| Net Debt Issuance | $457K | -$332K | $8M | $13M | $2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $4M | -$397K | -$131K | $408K |
| Financing Cash Flow | $5M | $11M | $8M | $14M | $7M |
| Net Change in Cash | $872K | $2M | -$2M | $4M | -$3M |
| Cash End of Period | $2M | $4M | $2M | $5M | $2M |
| Free Cash Flow | -$4M | -$8M | -$10M | -$10M | -$10M |